| Brian Eugene Lovelace, MD | |
|
4812 S 109th East Ave, Suite 100, Tulsa, OK 74146-5826 | |
| (918) 392-1400 | |
| (918) 236-4501 |
| Full Name | Brian Eugene Lovelace |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 21 Years |
| Location | 4812 S 109th East Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043359813 | NPI | - | NPPES |
| 200196160A | Other | OK | MEDICAID |
| OK400474 | Other | OK | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 23525 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St John Medical Center, Inc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tulsa Bone And Joint Associates Pc | 9335033802 | 70 |
News Archive
Many lines of evidence indicate that schizophrenia is a disorder of neurodevelopment. For example, genes implicated in the heritable risk for schizophrenia are also implicated in the development of nerve cells and their connections.
Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of tucatinib to capecitabine (Xeloda) and trastuzumab (Herceptin) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced HER2-positive breast cancer, with and without brain metastasis according to results of the HER2CLIMB clinical trial.
Cancer of the lower esophagus develops almost exclusively in patients with Barrett's esophagus, an otherwise benign complication of esophageal reflux that affects approximately 3 million Americans. Although the prognosis of patients diagnosed with esophageal cancer is poor, the chances of successful treatment increase significantly if the disease is detected at an early dysplastic stage.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 6 days ago
| Entity Name | Tulsa Bone & Joint Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154373132 PECOS PAC ID: 9335033802 Enrollment ID: O20040214000207 |
News Archive
Many lines of evidence indicate that schizophrenia is a disorder of neurodevelopment. For example, genes implicated in the heritable risk for schizophrenia are also implicated in the development of nerve cells and their connections.
Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of tucatinib to capecitabine (Xeloda) and trastuzumab (Herceptin) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced HER2-positive breast cancer, with and without brain metastasis according to results of the HER2CLIMB clinical trial.
Cancer of the lower esophagus develops almost exclusively in patients with Barrett's esophagus, an otherwise benign complication of esophageal reflux that affects approximately 3 million Americans. Although the prognosis of patients diagnosed with esophageal cancer is poor, the chances of successful treatment increase significantly if the disease is detected at an early dysplastic stage.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Eugene Lovelace, MD 4802 S 109th East Ave, Tulsa, OK 74146-5822 Ph: (918) 392-1400 | Brian Eugene Lovelace, MD 4812 S 109th East Ave, Suite 100, Tulsa, OK 74146-5826 Ph: (918) 392-1400 |
News Archive
Many lines of evidence indicate that schizophrenia is a disorder of neurodevelopment. For example, genes implicated in the heritable risk for schizophrenia are also implicated in the development of nerve cells and their connections.
Researchers from The University of Texas MD Anderson Cancer Center today reported study results showing the addition of tucatinib to capecitabine (Xeloda) and trastuzumab (Herceptin) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with advanced HER2-positive breast cancer, with and without brain metastasis according to results of the HER2CLIMB clinical trial.
Cancer of the lower esophagus develops almost exclusively in patients with Barrett's esophagus, an otherwise benign complication of esophageal reflux that affects approximately 3 million Americans. Although the prognosis of patients diagnosed with esophageal cancer is poor, the chances of successful treatment increase significantly if the disease is detected at an early dysplastic stage.
Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.
› Verified 6 days ago
Dr. Jaclyn Cinda Jones, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1245 S Utica Ave, Tulsa, OK 74104 Phone: 918-579-2590 Fax: 918-579-2599 | |
James F Bischoff, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2448 E 81st St Ste 1200, Tulsa, OK 74137 Phone: 918-900-6432 Fax: 918-392-7057 | |
Rodney L Plaster, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2448 E 81st St Ste 1520, Tulsa, OK 74137 Phone: 918-900-2520 Fax: 918-900-2521 | |
Dr. Wesley M Stotler, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4802 S 109th East Ave, Tulsa, OK 74146 Phone: 918-392-1400 Fax: 918-392-1488 | |
David R. Hicks, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6585 S Yale Ave Ste 200, Tulsa, OK 74136 Phone: 918-481-2767 Fax: 918-494-9277 | |
Sami Rumi Framjee, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2000 S Wheeling Ave, Suite 1110, Tulsa, OK 74104 Phone: 918-742-7339 Fax: 918-742-2119 | |
Mark Steven Schwartz, D.O. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6465 S Yale Ave, Suite 420, Tulsa, OK 74136 Phone: 918-502-8810 |